270 related articles for article (PubMed ID: 8032575)
21. Once daily theophylline: multiple-dose comparison of an encapsulated micro-osmotic system (Euphylong) with a tablet (Uniphyllin).
Steinijans VW; Schulz HU; Beier W; Radtke HW
Int J Clin Pharmacol Ther Toxicol; 1986 Aug; 24(8):438-47. PubMed ID: 3759279
[TBL] [Abstract][Full Text] [Related]
22. [Comparison of serum concentrations of once and twice daily administration of ultra-retard theophylline in school children with bronchial asthma].
Liebke C; Niggemann B; Wahn U
Pneumologie; 1996 Nov; 50(11):752-5. PubMed ID: 9082442
[TBL] [Abstract][Full Text] [Related]
23. Bioavailability of a slow-release theophylline capsule given twice daily to preschool children with chronic asthma: comparison with liquid theophylline.
Sallent J; Hill M; Stecenko A; McKenzie M; Hendeles L
Pediatrics; 1988 Jan; 81(1):116-20. PubMed ID: 3336577
[TBL] [Abstract][Full Text] [Related]
24. Pharmacokinetics of an oral once-a-day controlled-release oxybutynin formulation compared with immediate-release oxybutynin.
Gupta SK; Sathyan G
J Clin Pharmacol; 1999 Mar; 39(3):289-96. PubMed ID: 10073329
[TBL] [Abstract][Full Text] [Related]
25. Nocturnal asthma: effect of a once per evening dose of sustained release theophylline.
Neuenkirchen H; Wilkens JH; Oellerich M; Sybrecht GW
Eur J Respir Dis; 1985 Mar; 66(3):196-204. PubMed ID: 3884358
[TBL] [Abstract][Full Text] [Related]
26. Effects of cimetidine and ranitidine on the pharmacokinetics of a chronotherapeutically formulated once-daily theophylline preparation (Uniphyl).
Fraser IM; Buttoo KM; Walker SE; Stewart JH; Babul N
Clin Ther; 1993; 15(2):383-93. PubMed ID: 8519046
[TBL] [Abstract][Full Text] [Related]
27. [Chronotherapy concept and the pharmacokinetic validation of a theophylline retard preparation for once-nightly administration (Euphylong)].
Steinijans VW; Sauter R; Böhm A; Dietrich R; Benedikt G
Pneumologie; 1991 Nov; 45 Suppl 4():827-33. PubMed ID: 1812475
[TBL] [Abstract][Full Text] [Related]
28. Individualization of theophylline dosage: a Bayesian method evaluated in patients with once-daily dosing.
Martz W; Oellerich M; Schnabel D; Sybrecht GW
Ther Drug Monit; 1991 Sep; 13(5):420-4. PubMed ID: 1957334
[TBL] [Abstract][Full Text] [Related]
29. Pharmacokinetic characteristics of a new multiple unit sustained release formulation of sodium valproate.
Wangemann M; Retzow A; Vens-Cappell B
Int J Clin Pharmacol Ther; 1999 Feb; 37(2):100-8. PubMed ID: 10082174
[TBL] [Abstract][Full Text] [Related]
30. Theophylline steady-state pharmacokinetics: recent concepts and their application in chronotherapy of reactive airway diseases.
Steinijans VW; Trautmann H; Johnson E; Beier W
Chronobiol Int; 1987; 4(3):331-47. PubMed ID: 3315264
[TBL] [Abstract][Full Text] [Related]
31. [Pharmacokinetics and pharmacodynamics of twice-daily unequal administration of theophylline retard pellets in children of various age groups].
Berdel D; von Berg A; Reinhardt D; Heimann G; Steinijans VW; Sauter R
Pneumologie; 1991 Nov; 45 Suppl 4():863-6. PubMed ID: 1812481
[TBL] [Abstract][Full Text] [Related]
32. Pharmacokinetic characteristics of a new liquid sustained-release formulation of theophylline designed for the elderly and children: microcaps as sachet.
Fuchs WS; Weiss G; Von Nieciecki A; Laicher A; Gay S; Pabst G; Müller M
Int J Clin Pharmacol Ther; 1996 Dec; 34(12):558-63. PubMed ID: 8996853
[TBL] [Abstract][Full Text] [Related]
33. Pharmacokinetic properties of combination oxycodone plus racemic ibuprofen: two randomized, open-label, crossover studies in healthy adult volunteers.
Kapil R; Nolting A; Roy P; Fiske W; Benedek I; Abramowitz W
Clin Ther; 2004 Dec; 26(12):2015-25. PubMed ID: 15823765
[TBL] [Abstract][Full Text] [Related]
34. Pharmacokinetics of a new sustained-release formulation of theophylline sodium glycerinate in healthy subjects with a new asymmetric dosage regimen.
Wang P; Qi M; Zhong D; Fang L
Biomed Chromatogr; 2003 Jan; 17(1):58-61. PubMed ID: 12583008
[TBL] [Abstract][Full Text] [Related]
35. Twenty-four hour lung function in adult patients with asthma. Chronoptimized theophylline therapy once-daily dosing in the evening versus conventional twice-daily dosing.
D'Alonzo GE; Smolensky MH; Feldman S; Gianotti LA; Emerson MB; Staudinger H; Steinijans VW
Am Rev Respir Dis; 1990 Jul; 142(1):84-90. PubMed ID: 2195936
[TBL] [Abstract][Full Text] [Related]
36. Comparative absorption of theophylline following multiple doses of a sustained-release formulation and an elixir in humans.
Harrison LI; French IW; Mildon CA
Clin Ther; 1982; 4(6):489-96. PubMed ID: 7093982
[TBL] [Abstract][Full Text] [Related]
37. A novel slow-release formulation of lithium carbonate (Carbolithium Once-A-Day) vs. standard Carbolithium: a comparative pharmacokinetic study.
Castrogiovanni P
Clin Ter; 2002; 153(2):107-15. PubMed ID: 12078335
[TBL] [Abstract][Full Text] [Related]
38. Multiple-dose pharmacokinetics, pharmacodynamics, and safety of atorvastatin, an inhibitor of HMG-CoA reductase, in healthy subjects.
Cilla DD; Whitfield LR; Gibson DM; Sedman AJ; Posvar EL
Clin Pharmacol Ther; 1996 Dec; 60(6):687-95. PubMed ID: 8988072
[TBL] [Abstract][Full Text] [Related]
39. Theophylline disposition after single-dose ingestion of a once-a-day preparation (Dilatrane A. P. 400 mg) with and without breakfast.
Jonkman JH; Grasmeijer G; Holland A
Int J Clin Pharmacol Ther Toxicol; 1987 Nov; 25(11):633-7. PubMed ID: 3429067
[TBL] [Abstract][Full Text] [Related]
40. [Absorption profile and absolute bioavailability of a theophylline sustained-release preparation].
Pabst G; Weber W; Barkworth MF; Müller M; Rehm KD
Arzneimittelforschung; 1998 May; 48(5A):574-9. PubMed ID: 9676347
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
